Calamos Advisors LLC Sells 33,621 Shares of Genpact Limited (NYSE:G)

Calamos Advisors LLC lessened its position in shares of Genpact Limited (NYSE:G) by 57.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 24,399 shares of the business services provider’s stock after selling 33,621 shares during the period. Calamos Advisors LLC’s holdings in Genpact were worth $945,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Johnson Financial Group Inc. bought a new stake in Genpact during the 2nd quarter worth approximately $31,000. Captrust Financial Advisors increased its holdings in Genpact by 109.8% during the 2nd quarter. Captrust Financial Advisors now owns 1,072 shares of the business services provider’s stock worth $41,000 after acquiring an additional 561 shares during the period. Capital Bank & Trust Co bought a new stake in Genpact during the 2nd quarter worth approximately $78,000. Parallel Advisors LLC increased its holdings in Genpact by 741.2% during the 2nd quarter. Parallel Advisors LLC now owns 3,003 shares of the business services provider’s stock worth $114,000 after acquiring an additional 2,646 shares during the period. Finally, SRS Capital Advisors Inc. bought a new stake in Genpact during the 2nd quarter worth approximately $133,000. 94.79% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director David Humphrey sold 3,000 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $17.10, for a total value of $51,300.00. Following the completion of the sale, the director now owns 4,500 shares of the company’s stock, valued at approximately $76,950. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Bain Capital Investors Llc sold 10,621,804 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $40.51, for a total transaction of $430,289,280.04. The disclosure for this sale can be found here. Insiders sold a total of 12,580,720 shares of company stock worth $509,578,468 in the last three months. Insiders own 1.86% of the company’s stock.

G has been the topic of a number of analyst reports. ValuEngine lowered shares of Genpact from a “buy” rating to a “hold” rating in a report on Friday, September 27th. Cantor Fitzgerald upped their target price on shares of Genpact from $40.00 to $47.00 and gave the stock an “overweight” rating in a report on Thursday, August 8th. Deutsche Bank upped their target price on shares of Genpact from $36.00 to $44.00 and gave the stock a “hold” rating in a report on Thursday, August 8th. Zacks Investment Research raised shares of Genpact from a “sell” rating to a “hold” rating and set a $43.00 price target on the stock in a report on Thursday, September 12th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $48.00 price target (up previously from $44.00) on shares of Genpact in a report on Thursday, August 8th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $39.70.

Shares of NYSE:G opened at $38.55 on Friday. The company’s fifty day moving average price is $39.03 and its 200-day moving average price is $38.17. The firm has a market capitalization of $7.21 billion, a price-to-earnings ratio of 24.09, a PEG ratio of 2.00 and a beta of 0.80. Genpact Limited has a one year low of $25.48 and a one year high of $44.55. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.46 and a quick ratio of 1.46.

Genpact (NYSE:G) last issued its quarterly earnings results on Wednesday, August 7th. The business services provider reported $0.41 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.41. The firm had revenue of $882.79 million for the quarter, compared to analyst estimates of $824.84 million. Genpact had a net margin of 8.77% and a return on equity of 21.87%. The business’s revenue for the quarter was up 21.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.41 EPS. As a group, equities research analysts expect that Genpact Limited will post 1.69 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Monday, December 9th will be issued a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date is Friday, December 6th. Genpact’s payout ratio is 21.25%.

About Genpact

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

Further Reading: Why do companies issue stock splits?

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.